Clin2
NCT07337655Possibly a fitNot yet recruiting

Aspirin and Lansoprazole to Prevent Early Birth in High-Risk Pregnancies

Pre-term Birth

Part of Women’s health & pregnancy clinical trials.

This trial tests whether daily aspirin plus a stomach-protecting medicine (lansoprazole) can help prevent early birth in women who are at high risk. It's for pregnant women aged 18–45 with a single baby, who are 12–16 weeks along and have a greater chance of delivering before 37 weeks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
670 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You are pregnant with a single baby (not twins or triplets), confirmed by ultrasound.
  • You are between 12 and just under 17 weeks pregnant when you start the study.
  • You have a higher risk of giving birth early because you've had a previous early birth, a short cervix, or another risk factor your doctor has identified.
  • You have no known allergies or intolerances to aspirin, other NSAIDs, or the stomach medicine lansoprazole.
  • You do not have a bleeding disorder or serious medical conditions that would make aspirin or lansoprazole unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06980025Recruiting· Phase 3
Aspirin dose trial to prevent preterm birth

This study tests if a higher dose of aspirin can help prevent another early delivery in women who have had a preterm birth before. If you qualify, you would take either a standard or escalated dose of aspirin during your current pregnancy.

Birmingham, Alabama
NCT07745595Not yet recruiting
Low dose aspirin to prevent recurrent preterm birth

This study tests whether taking a low dose of aspirin every day can help prevent another early birth in women who have had a preterm birth before. It compares aspirin to a placebo (a pill with no active medicine) to see if it is safe and effective.

NCT06408181Recruiting· Phase 3
Aspirin to prevent pregnancy loss and preeclampsia

This study tests whether taking a daily low-dose aspirin can help prevent pregnancy loss and preeclampsia. It's for women who are in early pregnancy and have certain health risks.

Philadelphia, Pennsylvania
NCT07665853Not yet recruiting· Phase 3
Aspirin to prevent preeclampsia in high-risk pregnancies

This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.

Vienna
NCT07614893Not yet recruiting
Testing alerts to help doctors prescribe aspirin for pregnancy safety

This trial tests whether sending reminders to doctors helps them prescribe low-dose aspirin to pregnant patients at higher risk of preeclampsia (a serious pregnancy condition). Aspirin early in pregnancy may help prevent preeclampsia if you have risk factors.

Boston, Massachusetts
NCT06111079Recruiting· Phase 3
Stopping Aspirin in High-Risk Pregnant Women

This trial tests whether stopping aspirin use in high-risk pregnant women can be safe. It aims to find the best time to stop taking aspirin to prevent preeclampsia, a condition that causes high blood pressure during pregnancy.

Guangzhou, Guangdong

Hear when a new Pre Term Birth trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.